Medace Tablet contains Medroxyprogesterone acetate 10 mg, a synthetic progestin used primarily in hormone replacement therapy, menstrual disorders, and as a contraceptive agent. Medroxyprogesterone acetate acts by mimicking the natural hormone progesterone, regulating the menstrual cycle and maintaining the endometrium. It is indicated for the treatment of secondary amenorrhea, abnormal uterine bleeding due to hormonal imbalance, and as part of combination therapy for endometriosis. Additionally, Medace is utilized in hormone replacement therapy to counteract estrogen-induced endometrial hyperplasia in postmenopausal women. The tablet is administered orally, with dosage tailored according to the specific condition and patient response. Common side effects may include headache, breast tenderness, weight changes, and mood alterations. Contraindications include known hypersensitivity to medroxyprogesterone acetate, active thromboembolic disorders, liver dysfunction, and undiagnosed vaginal bleeding. Caution is advised in patients with a history of cardiovascular disease, diabetes, or epilepsy. Regular monitoring by a healthcare professional is recommended to assess therapeutic efficacy and detect potential adverse effects. Medace Tablet should be prescribed and used under medical supervision to ensure safe and effective treatment outcomes.